Article
Cellular changes in boric acid-treated DU-145 prostate cancer cells.
British journal of cancer - 27 Mar 2006
Barranco W T, Eckhert C D
Abstract excerpt
Epidemiological, animal, and cell culture studies have identified boron as a chemopreventative agent in prostate cancer. The present objective was to identify boron-induced changes in the DU-145 human prostate cancer cell line. We show that prolonged exposure to pharmacologically-relevant levels of boric acid, the naturally occurring form of boron circulating in human plasma, induces the following morphological...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
